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INFLUENCE OF BASAL RELEASE OF NITRIC OXIDE ON SYSTOLIC AND DIASTOLIC FUNCTION 
OF BOTH VENTRICLES 
Pankaj Mankad, FRCS(C/Th) 
Magdi Yacoub, FRCS 
Nitric oxide is continuously released by coronary artery endothelium under 
basal conditions; it maintains vascular tone and regulates coronary blood 
flow. The objective of this study was to investigate the influence of this basal 
release of nitric oxide on right and left ventricular systolic and diastolic 
function. Isolated pig hearts perfused at a constant pressure with enriched 
autologous blood were used. Systolic and diastolic pressure-volume rela- 
tionships of isovolumically contracting hearts were studied in the control 
setting and after addition of 1 mmol/L L-NG-monomethyl-arginine followed 
by 5 mmol/L L-arginine to the perfusate. Addition of L.NG-monomethyl - 
arginine caused an acute rise in coronary vascular resistance and a 
reduction in right and left ventricular systolic function as evaluated by the 
slope values of the pressure-volume curves, but had little effect on the 
diastolic function of either ventricle. L-Arginine restored the systolic 
function to the control evel. This alteration in ventricular function was not 
a result of ischemia because myocardial oxygen consumption was not 
significantly affected by the acute increase in coronary vascular esistance 
induced by L-NG-monomethyl-arginine. W  canclude that basal release of 
nitric oxide has no direct negative inotropic effect, but in fact plays an 
important role in preserving right and left ventricular systolic function and 
maintains the basal coronary vascular tone. (J Thorac Cardiovasc Surg 
1997;113:770-6) 
N itric oxide (NO) is released continuously from endothelial cells under basal conditions by 
enzymatic onversion of endogenous L-arginine. 1
It modulates vascular tone in large and small 
coronary arteries. Inhibition of NO synthesis 
causes reduction in myocardial blood flow in ex 
vivo experiments 2 and produces coronary vaso- 
constriction in in vivo studies. 3 However, the role 
of the basal release of NO in maintaining myocar- 
dial function in the normal heart has not been 
adequately investigated. 
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We have previously shown that inhibition of basal 
NO release in the rat heart leads to depression of 
mechanical function. 4 In these experiments, hearts 
were perfused with crystalloid solution. Perfusion of 
the isolated heart with blood for evaluation of 
myocardial function has obvious advantages. In ad- 
dition, global myocardial function includes systolic 
and diastolic ventricular functions. There is evi- 
dence to suggest hat one of the functions can be 
affected without apparent change in the other. In 
addition, for proper evaluation of myocardial func- 
tion, it is imperative to study the function of both 
right and left ventricles imultaneously. With the use 
of L-NG-monomethyl-arginine (L-NMMA), a selec- 
tive inhibitor of NO synthesis and L-arginine, we 
have investigated the influence of basal release of 
NO in maintaining right and left ventricular systolic 
and diastolic functions in the blood-perfused iso- 
lated pig heart. 
Methods 
Experimental design. Nine pigs of either sex, weighing 
between 45 to 62 kg each, were given atropine sulphate 
(40 /,g/kg) plus ketamine hydrochloride (10 mg/kg) and 
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anesthetized with intravenous propofol (3 mg/kg). They 
were intubated and supported on a volume-controlled 
ventilator. The anesthesia was maintained with 60% oxy- 
gen and 40% nitrous oxide (4 to 6 L/min). Pancuronium 
bromide (0.08 mg/kg) was given before performance of a 
median sternotomy. While the chest was being opened, 2 
units of blood (each unit approximately 500 ml) was 
collected via a cannula inserted into a femoral artery to 
prime the perfusion circuit for functional evaluation. The 
pigs were heparinized with 300 IU/kg of beef-lung hepa- 
rin. The pericardium was opened and the heart isolated, 
excised, and immediately immersed in cold (4 ° C) Ring- 
er's solution (Travenol Laboratories Ltd., Thetford, Nor- 
folk, England). Prompt diastolic arrest was achieved by 
infusion of 300 ml of St. Thomas' Hospital cardioplegic 
solution (David Bull Laboratories, Mulgrave, Victoria, 
Australia), cooled to 4 ° C, into the aortic root. The hearts 
were weighed immediately after arrest and replaced in 
cold Ringer's solution. 
While the heart was still immersed in cold Ringer's 
solution, intraventricular balloons connected to a pressure 
transducer were sutured to the annuli of the tricuspid and 
mitral valves. The left ventricle was vented by a small 
apical stab incision. A thermistor probe was inserted into 
the interventricular septum for continuous monitoring of 
myocardial temperature. The sinus node was crushed and 
two pacing wires were sutured to the right atrium. The 
aortic arch was clamped, a cannula was inserted into the 
innominate artery, and both the aorta and the cannula 
were deaired. The heart was then mounted on a retro- 
grade perfusion apparatus consisting of a Watson-Marlow 
roller pump (Smith & Nephew Watson-Marlow, Corn- 
wall, England), a Capiox 300 hollow-fiber oxygenator with 
integrated heat exchanger (Terumo Corporation, Tokyo, 
Japan), and a 40 txm blood filter (LPE 1440, Ultipor blood 
filter, Pall Biomedical Ltd., Portsmouth, England) via the 
cannula in the innominate artery and placed inside an 
insulated glass cylinder. The heart was immediately per- 
fused in a nonpulsatile retrograde fashion with enriched 
autologous blood (hematocrit 24% to 28%) containing 
I>ribose 1 gm/L, insulin 20 IU/L, and glucose 14.25 
mg/min at an aortic pressure of 50 mm Hg and perfusate 
temperature of 28 ° C. After 5 minutes of perfusion under 
these conditions, the aortic pressure was increased to 80 
mm Hg and the temperature brought up to 37 ° C. The 
hearts were paced at a constant rate of 120 beats/min. 
Coronary flow was measured continuously by an on-line 
electromagnetic blood flow probe connected to a cali- 
brated flow meter (Nihon-Kohden Corporation, Tokyo, 
Japan). 
Experimental protocol. After 20 minutes of perfusion, 
samples of blood were collected from the arterial ine and 
from the coronary sinus for the measurement of oxygen 
content. Functional evaluation of the isovolumically con- 
tracting hearts was aided by previously introduced intra- 
ventricular balloons and done by the method escribed by 
Weber, Janicki, and Shroff. 5 Six hearts were used for these 
experiments. The zero volume for isovolumic ventricular 
contraction, defined as the volume at which the ventricle 
generates a diastolic pressure of 1 to 2 mm Hg, was 
determined for both ventricles by introduction of a mea- 
sured quantity of normal saline solution into the intraven- 
tricular balloons. The balloons were then sequentially 
inflated with 10, 20, 30, and 40 mt of saline solution. At 
each balloon volume, transballoon left ventricular systolic 
and diastolic and right ventricular systolic and diastolic 
pressures were recorded (control data). 
L-NMMA was then added to the perfusate to give the 
final concentration of the antagonist at 1 mmol/L. This 
dose was selected on the basis of a number of observations 
in control experiments. Three pig hearts were perfused 
with incremental doses of L-NMMA starting from 10 -5 
mol/L and increasing by 10 -1 mol/L up to a maximum of 
10 2 moI/L. This resulted in an acute increase in coronary 
vascular esistance (CVR) as determined by the quotient 
of perfusion pressure (in millimeters of mercury) and 
coronary flow (milliliters per minute) per gram heart 
weight. The dose of L-NMMA (1 mmol/L) that gave the 
maximum increase in CVR was selected for further ex- 
periments. The speed of the perfusion pump was adjusted 
to maintain perfusion pressure at 80 mm Hg. This resulted 
in reduction in coronary flow. The new value of coronary 
flow was recorded. After 15 minutes, arterial and coronary 
sinus blood samples were collected to measure oxygen 
content, and left and right ventricular functions were 
remeasured as described before (post-L-NMMA data). 
L-Arginine was next added to the perfusate to achieve a 
final concentration of 5 mmol/L Perfusion pressure was 
maintained at 80 mm Hg. Coronary flow was recorded, 
and after 20 minutes of perfusion ventricular function was 
assessed as before (post-L-arginine data). 
The stability of this preparation was determined by 
serial (every 15 minutes) evaluation of ventricular func- 
tion in three experiments during continuous perfusion of 
hearts, without any additives to the perfusate, over 60 
minutes. In three additional experiments, after the assess- 
ment of control ventricular function, L-arginine was added 
to the perfusate (5 mmol/L), CVR was recorded, and after 
20 minutes repeat measurement of ventricular function 
was undertaken. The investigations were performed in 
accordance with the Guidance on the Operation of the 
Animals (Scientific Procedures) act of 1986, published by 
Her Majesty's Stationery Office, London. 
Myocardial oxygen consumption. Myocardial oxygen 
consumption (MVOa) was calculated from the oxygen 
content of arterial and coronary venous blood. The value 
was normalized with respect o the heart weight o give an 
MVO: in milliliters of Oa per beat per 100 gm of heart 
weight. 
Myocardial function evaluation. From the values of 
transballoon systolic and diastolic pressures obtained at 
different balloon volumes, pressure-volume (P-V) curves 
were plotted for both the right and left ventricles. The 
slope of the systolic P-V curve, that is, peak elastance (in 
millimeters of mercury per milliliter), and the inverse 
slope of the diastolic curve, that is, ventricular compli- 
ance, were used as indices of systolic and diastolic ven- 
tricular functions, respectively. The slope values of dia- 
stolic P-V curves were obtained by plotting a regression 
line through the P-V points. 
Expression of results. The control and post-L-NMMA 
data on MVO 2 were analyzed by a paired t test. The 
control, post-L-NMMA, and post-L-arginine values of 
right and left ventricular elastance and compliance were 
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Fig. 1. An example, at the balloon volume of 40 ml, of 
the analog tracings used to generate a typical eft ventric- 
ular P-V curve. The top tracing shows the control data, the 
middle tracing data after L-NMMA administration a d the 
bottom tracing data after addition of L-arginine to the 
perfusate. 
analyzed and compared for statistical significance by 
analysis of variance with Scheffe's correction. Significance 
was assumed when the p value was less than 0.05. All 
values are expressed as the mean plus or minus the 
standard eviation. 
Results 
There was no significant difference in the absolute 
values of systolic and diastolic pressures at different 
balloon volumes in the control experiments in which 
ventricular function was measured over 60 minutes 
of continuous perfusion without any additives. An 
example of the analogue tracings used to generate 
P-V curves is shown in Fig. 1. 
Control, post-L-NMMA, and post-L-arginine cor- 
onary flow and CVR. Table I shows the coronary 
flow and the CVR in the control setting, after 
addition of L-NMMA, and after reversal of the effect 
of L-NMMA by L-arginine. Table I also depicts the 
representative alues for right and left ventricular 
systolic and diastolic pressures at 20 ml balloon 
volume. Control coronary flow was 2.025 + 0.14 
ml/min per kilogram. CVR in the control conditions 
was 39.7 _+ 2.6 mm Hg/ml per minute per gram heart 
weight (n - 61. Soon after the addition of L-NMMA, 
this rose to 62.9 _ 5.7 mm Hg/ml per minute per 
gram heart weight (p < 0.001), whereas after the 
addition of L-arginine there was a significant reduc- 
tion compared with post-L-NMMA values to 44.5 
2.8 mm Hg/ml per minute per gram heart weight 
(p < 0.001). Though the addition of L-arginine 
counteracted the increase m CVR induced by L- 
NMMA, the values were still significantly higher as 
compared with the control observations (p - 
0.0115). 
Control and post-L-NMMA MVO 2. Table I shows 
the difference in oxygen content of arterial and coro- 
nary sinus blood plus the values of MVO 2 before and 
after infusion of the preparation with L-NMMA. After 
L-NMMA was added to the preparation, the myocar- 
dium extracted an increased amount of oxygen from 
the arterial blood to compensate for the reduced flow. 
There was no significant difference in the MVO 2 in the 
control setting, after the addition of L-NMMA, or after 
L-arginine infusion. 
Control and post-L-NMMA ventrieular function, 
Control and post-L-NMMA left and right ventricu- 
lar systolic and diastolic function curves are plotted 
in Figs. 2 and 3. The addition of L-NMMA caused a 
shift to the right of the left and right ventricular 
systolic P-V curves and resulted in reduction in the 
peak systolic elastance. The control left ventricular 
elastance of 4.55 : 0.63 mm Hg/ml was reduced to 
3.08 -:_ 0.24 mm Hg/ml (p < 0.001 ); the control right 
ventricular elastance of 2.32 ~ 0.44 mm Hg/ml was 
reduced to 1.36 ~- 0.31 mm Hg/ml after L-NMMA 
addition (p : 0.0014). The percentage r ductions in 
elastance from the control values for the left and 
right ventricles were 31.2% _ 9.7% and 41.0% ~- 
12.04%, respectively. 
L-NMMA caused a shift to the right of the 
diastolic P-V curve and resulted in an increase in 
both left and right ventricular compliances as com- 
pared with the control values. The left ventricular 
compliance rose from 1.03 ~- 0.13 mm Hg/ml to 
1.57 _+ 0.21 mm Hg/ml (p < 0.001); the right 
ventricular compliance changed from 0.96 + 0.21 
mm Hg/ml to 1.08 + 0.18 mm Hg/ml (p - 0.324). 
Post-L-NMMA and post-L-arginine ventrieular 
function. Figs. 2 and 3 show the left and right 
ventricular systolic and diastolic function curves 
after the addition of L-NMMA and L-arginine to the 
perfusate. The L-NMMA-induced decrease in sys- 
tolic elastance of both ventricles was partially re- 
stored by L-arginine. Left ventricular elastance in- 
creased from 3.08 + 0.24 mm Hg/ml to 4.34 + 0.42 
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Table I. Findings in the control setting and after addition of 1 mmol/L L-NMMA followed by addition of 5 
mmol/L L-arginine to blood-perfused, isolated, isovolumically contracting pig hearts (n = 6) 
CVR L V systolic LV diastolic RV systolic RV diastolic 
Coronary flow (ram Hg/ml/ pressure pressure pressure pressure Ac-V~ 341/02 
(ml/min) gm/rnin) (mm Hg) (ram Hg) (mm Hg) (mm Hg) (vol %) (rnl/beat/lO0 gin) 
Control 427.5 _+ 49.7 39.65 -+ 2.57 125 _+ 9.7 6.3 _+ 1.37 59.8 -+ 4.9 7.8 -+ 1.47 1.75 _+ 0.22 29.48 -+ 3.52 
Post-L-NMMA 270.0 _+ 32.9* 62.9 _+ 5.66* 96.7 _+ 11.1 5.5 _+ 1.5 45 -+ 6.6 8.2 _+ 1.2 2.82 + 0.52* 29.7 _+ 3.717 
Post-L-arginine 380.0 -+ 31.8~:§ 44.45 -+ 2.81~:[[ 114.3 _+ 11.1 7.7 -+ 1.0 59.7 -+ 7.1 8.5 -+ 1.0 2.11 _+ 0.46 31.4 + 4.08 
For details of the experimental protocol, refer to the text. Left and right ventricular pressures are those at a balloon volume of 20 ml. Values are mean plus 
or minus the standard eviations. LV,, left ventricular; RV,, right ventricular; Ac-Vc, myocardial oxygen extraction. 
*p < 0.001 compared with control value. 
tp ~ 0.8736 compared with control value. 
:)p < 0.001 compared with post-L-NMMA value. 
§p = 0.077 compared with control value. 
lip = 0.0115 compared with control value. 
mm Hg/ml (p < 0.001) and right ventricular elas- 
tance improved from 1.36 _+ 0.31 mm Hg/ml to 
2.26 + 0.42 mm Hg/ml (p = 0.0017). Though the 
post-L-arginine values of elastance were slightly 
higher as compared with the control observations, 
there was no significant difference between them. 
Compliances of both ventricles were also restored 
by L-arginine. Left ventricular compliance was 
1.24 + 0.22 mm Hg/ml after L-arginine as opposed 
to 1.57 + 0.21 mm Hg/ml after L-NMMA (p = 
0.025). Right ventricular compliance, after L-argi- 
nine, was 0.94 -+ 0.16 mm Hg/ml in comparison with 
1.08 _+ 0.18 mm Hg/ml after L-NMMA (p = 0.181). 
There was no significant difference between the 
post-L-arginine values of compliances and the con- 
trol observations. 
Addition of L-arginine to the perfusate immedi- 
ately after control observations had no significant 
effect on CVR or ventricular systolic and diastolic 
functions. 
Discussion 
We have shown that in the isolated pig heart, 
coronary vascular tone is affected by continuous 
basal release of endothelium-derived NO, but block- 
ade of this NO release does not lead to a state of 
myocardial ischemia. We have also shown that the 
basal release is critical for preserving systolic func- 
tion of both the right and left ventricles. However, in 
this study little direct effect of basal NO on the 
diastolic function of ventricles was observed. 
Under basal conditions NO is released by endo- 
thelium in response to mechanical factors such as 
shear stress and pulsatile floW. 6' 7 Several possible 
mechanisms may account for the observed effects of 
NO in our experiments. First, L-NMMA itself could 
have direct negative inotropic effects on the myocar- 
dium. This is, however, unlikely inasmuch as in 
myocyte xperiments done with use of the method 
described by Harding and associates 8 we have pre- 
viously shown that in isolated rat myocytes 
L-NMMA (1 mmol/L) has no significant effect on 
the amplitude of contraction or on velocities of 
contraction and relaxation. 4 Second, addition of 
L-NMMA reduces coronary blood flow and pro- 
duces a state of myocardial ischemia causing dimin- 
ished contractility. This is an unlikely explanation 
because MVO 2 in our experiments remained unaf- 
fected by blockade of NO release. This confirms 
previous observations in isolated rat and in vivo pig 
hearts that inhibition of NO synthesis reduces cor- 
onary flow but does not induce a state of ischemia. 9 
Third, NO inhibits norepinephrine r lease from 
sympathetic nerve endings. I° L-NMMA may en- 
hance the release of norepinephrine and affect 
myocardial function. If so, its effect on myocardial 
contractility would be opposite of that encountered 
in our experiments. In these experiments hearts 
were isolated, that is, denervated, which thus makes 
this possible xplanation i valid. Fourth, it is, there- 
fore, most likely that the noted effect of basal NO 
release on myocardial systolic function was its direct 
action mediated by the cyclic guanosine monophos- 
phate pathway. However, the observed increase in 
ventricular compliance after suppression of basal 
NO release by 5-NMMA, suggesting preserved ia- 
stolic function, was a paradoxic finding. This is most 
likely to be an indirect effect. Diastolic properties of 
ventricles are affected by coronary blood volume. 11 
A modest increment in the end-diastolic P-V rela- 
tionship is observed with an elevation in coronary 
perfusion pressure and flow. The reverse holds true 
if there is a decrease in coronary perfusion pressure 
and flow. A decrease in the total coronary blood 
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Fig. 2. Left ventricular systolic (S) and diastolic (D) P-V relationships of isovolumically contracting 
isolated pig hearts (n = 6) in the control setting (open circles), after infusion of 1 mmol/L L-NMMA to the 
blood perfusate (solid triangles), and after reversal of this effect by addition of 5 mmol/L L-arginine (solid 
circles). *p < 0.001, **p < 0.001 compared with the control values; #p < 0.001, ##p = 0.025 compared 
with post-L-NMMA values; ns, not significant compared with the control values. Thep values refer to the 
ventricular elastance and compliance. 
volume is, therefore, a most likely explanation for 
the apparent rightward shift in the diastolic P-V 
relation observed after suppression of NO release 
with L-NMMA. 
In this study we used an isolated pig heart to 
assess ventricular function. There are several advan- 
tages in using this model. It is a denervated prepa- 
ration; therefore myocardial function is not de- 
pendent on neurohumoral factors. Because the 
preparation is blood perfused and the hearts are 
subjected to cold cardioplegic arrest the in vivo 
situation encountered in cardiac operations and 
transplantation is simulated. The model allows crit- 
ical assessment of both right and left ventricular 
systolic and diastolic functions. The limitations of 
this model include the nonpulsatile nature of perfu- 
sion and a closed recirculating preparation. Because 
pulsatility is a strong stimulus for basal NO release, 
it is conceivable that this preparation without pulsa- 
tility would have lower basal NO release than the in 
vivo situation. The failure of L-arginine to com- 
pletely reverse the effects of L-NMMA could be a 
result of the time lag between L-NMMA adminis- 
tration and L-arginine infusion. Because the interac- 
tion between I.-arginine and L-NMMA is competi- 
tive, the effects may be seen more clearly if 
L-arginine is infused from the beginning of the 
experiments. This difference could also be due to 
mechanical or pharmacokinetic changes in the mi- 
crocirculation caused by the edema that may de- 
velop during the experiment. 
The observed effect of physiologic NO re lease is 
in contrast o the action of pathologic quantities of 
NO on myocytes. 12It has been shown that stimu- 
lated release of NO has negative inotropic ef- 
fects. 1214 Excessive production of NO, which occurs 
in conditions uch as endotoxemia, reduces myocyte 
contractiiity13; this effect is identical to the action of 
cytokines on mammalian hearts, which is also me- 
diated by NO.  14 These paradoxic effects of NO on 
myocytes could be due to the different mechanisms 
that operate in its release. 15 Basal release is physi- 
ologic and occurs by continuous stimulation of 
constitutive NO synthatase, whereas excessive re- 
lease is triggered by activation of inducible NO 
synthatase in certain pathologic onditions. 
The effects of physiologic NO release on myocar- 
dial function have been studied by other investiga- 
tors. In isolated ejecting uinea pig hearts, Grocott- 
Mason and associates a6showed that exogenous NO 
typically enhances myocardial relaxation and re- 
duces diastolic tone, without significantly altering 
the rate of force or pressure development; in human 
beings, the same group showed that endogenous NO 
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ventricular elastance and compliance. 
modulates left ventricular elaxation in the intact 
heart. 17 An influence of basal NO on left ventricular 
diastolic filling parameters has also been shown by 
Clarkson, Lim, and MacDonald Is in normal volun- 
teers. In our experiments no direct effect on myo- 
cardial diastolic function was observed. This could 
be due to the limitation of the preparation or the 
lesser sensitiviw of the measured parameter of 
diastolic function. Mohan, Sys, and Brutsaert 19 
showed a concentration-dependent positive inotro- 
pic effect of NO-releasing nitrovasodilators in iso- 
lated cat papillary muscle. With the same prepara- 
tion they also showed that NO and prostaglandins 
released from endocardial endothelium interact 
with each other to regulate myocardial perfor- 
mance. 2° In our study the effects of NO released 
from vascular endothelium or from endocardial 
endothelium 21could not be separated. However, the 
effects of vascular endothelium on myocardial con- 
tractile characteristics have been shown to be similar 
to those of endocardial endothelium in rat ventric- 
ular papillary muscles after Langendorff perfusion~ 22 
It is likely that the observed effects of NO suppres- 
sion in our experiments were due to inhibition of 
both vascular and endocardial NO. 
The clinical implications of these findings are 
manifold. Endothelial function is often adversely 
affected by ischemia nd reperfusion during routine 
cardiac operations and transplantationY '24 It is 
conceivable that diminished basal release of NO in 
this setting contributes to reduction in myocardial 
systolic function and forms a part of reperfusion 
injury. In this context, it has recently been shown 
that in experimental preparations addition of the 
NO precursor I.-arginine or of an NO donor during 
ischem!a-reperfusion leads to improved recovery of 
myocardial contractile function. 25-27 Coronary an- 
gioplasty, an established procedure for certain pa- 
tients with coronary artery disease, also leads to 
endothelial damage and dysfunction. 2s Significant 
depression in ventricular function has been de- 
scribed uring angioplasty, which Often persists after 
successful balloon dilation.In this study the short- 
term influence of suppression ofbasal release of NO 
on myocardial function was reversible; however, it is 
possible that long periods of ischemia could result in 
a certain degree of irreversible myocardial damage 
in patients with coronary artery disease. 
In summary, we have shown that basal release of 
NO, unlike stimulated pathologic release, has no 
direct negative inotropic effect but in fact plays an 
important role in preserving right and left ventricu- 
lar systolic function and maintains the basal coro- 
nary vascular tone. Further clinical studies are 
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needed to eva luate the ro le of  NO in the recovery  of  
myocard ia l  funct ion after  i schemia and reper fu-  
sion. 29 This could have a signif icant impact  on the 
early results of  card iac operat ions  and transplanta-  
tion. 
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